CGAS and neoplasm: Specifically, the POLE mutation leads to genomic instability and increased DNA damage, upregulates cytoplasmic DNA, triggers cGAS, and initiates downstream signaling, thereby stimulating the expression of inflammatory genes and anti-tumor immune responses.